Inventor
STERLING JEFF
IL12 patents
⚠️ This page may combine multiple inventors who share the name “STERLING JEFF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMA
10 patentsUS5877218AMar 2, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA153 citations97
US6528685B2Mar 4, 2003
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA47 citations96
US6277886B1Aug 21, 2001
Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan
TEVA PHARMA66 citations96
US5914349AJun 22, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA50 citations96
US5877221AMar 2, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA52 citations96
US5994408ANov 30, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA54 citations95
US5466683ANov 14, 1995
Water-soluble analogs of carbamazepine
TEVA PHARMA74 citations95
US6271263B1Aug 7, 2001
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA35 citations94
US5880159AMar 9, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA47 citations94
US5486541AJan 23, 1996
Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase
TEVA PHARMA114 citations92